treatments in Czech Republic

Combination Carfilzomib and dexamethasone

Available in Czech Republic?
Reimbursement statusNo
Available compassionate use programmes (adults & children)

Combination Carfilzomib, lenalidomide and dexamethasone

Available in Czech Republic?
Reimbursement statusYes
Available compassionate use programmes (adults & children)

Bortezomib in combination with thalidomide and dexamethasone

Available in Czech Republic?
Reimbursement statusYes
Available compassionate use programmes (adults & children)

Bortezomib in combination with melphalan and prednisolone

Available in Czech Republic?
Reimbursement statusYes
Available compassionate use programmes (adults & children)

Bortezomib as a monotherapy

Available in Czech Republic?
Reimbursement statusYes
Available compassionate use programmes (adults & children)

Daratumumab in combination with bortezomib and dexamethasone

Available in Czech Republic?
Reimbursement statusNo
Available compassionate use programmes (adults & children)

Daratumumab in combination with lenalidomide and dexamethasone

Available in Czech Republic?
Reimbursement statusYes
Available compassionate use programmes (adults & children)

Daratumumab as a monotherapy

Available in Czech Republic?
Reimbursement statusNo
Available compassionate use programmes (adults & children)

Elotuzumab in combination with lenalidomide and dexamethasone

Available in Czech Republic?
Reimbursement statusNo
Available compassionate use programmes (adults & children)

Ixazomib in combination with lenalidomide and dexamethasone

Available in Czech Republic?
Reimbursement statusNo
Available compassionate use programmes (adults & children)

Lenalidomide combination with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone

Available in Czech Republic?
Reimbursement statusYes
Available compassionate use programmes (adults & children)

Lenalidomide as a monotherapy

Available in Czech Republic?
Reimbursement statusNo
Available compassionate use programmes (adults & children)

Panobinostat in combination with bortezomib and dexamethasone

Available in Czech Republic?
Reimbursement statusNo
Available compassionate use programmes (adults & children)

Pomalidomide in combination with bortezomib and dexamethasone

Available in Czech Republic?
Reimbursement statusYes
Available compassionate use programmes (adults & children)

Thalidomide as a monotherapy

Available in Czech Republic?
Reimbursement statusNo
Available compassionate use programmes (adults & children)
1

on-going clinical trials

As of November 2020, there are no recruiting nor active, not recruiting clinical trials on Multiple Myeloma in the country.

Click here to access a list of Multiple Myeloma clinical trials in Europe.

ERN Centers in Czech Republic

ERN centres part of European network for Rare Hematological Diseases – EuroBloodNet. More information is available on EuroBloodNet official website.

  1. University hospital Brno
    ihlavská 340/20
    625 00 Brno-Bohunice-Brno-Starý Lískovec
    Ph.: +420 532 231 111
    https://www.fnbrno.cz